Exhibit (a)(49)

- --------------------------------------------------------------------------------
                     Supplement No. 4 Dated August 14, 2006
             Relating to the Amended and Restated Offer to Purchase
                         Dated May 24, 2005, as Amended
- --------------------------------------------------------------------------------

                             LOLA BROWN TRUST NO. 1B

                   Has Amended Its Offer to Purchase for Cash
               Up to 1,620,000 Outstanding Shares of Common Stock
                                       of
                  NEUBERGER BERMAN REAL ESTATE INCOME FUND INC.
                                       at
                              $19.89 Net Per Share

THE OFFER AND  WITHDRAWAL  RIGHTS  HAVE BEEN  EXTENDED,  AND WILL EXPIRE AT 5:00
P.M.,  NEW YORK CITY TIME,  ON  FRIDAY,  DECEMBER  8, 2006,  UNLESS THE OFFER IS
FURTHER EXTENDED.

THE OFFER IS NOT  CONDITIONED  UPON THE RECEIPT OF FINANCING OR UPON ANY MINIMUM
NUMBER OF SHARES BEING TENDERED. THE OFFER IS SUBJECT TO CERTAIN CONDITIONS. SEE
"THE OFFER -- SECTION 14."

NEITHER  THE  SECURITIES  AND  EXCHANGE  COMMISSION  NOR  ANY  STATE  SECURITIES
COMMISSION HAS APPROVED OR  DISAPPROVED  OF THIS  TRANSACTION OR PASSED UPON THE
MERITS OR FAIRNESS OF THIS  TRANSACTION  OR PASSED UPON THE ADEQUACY OR ACCURACY
OF THE INFORMATION CONTAINED IN THE OFFER OR THIS SUPPLEMENT. ANY REPRESENTATION
TO THE CONTRARY IS A CRIMINAL OFFENSE.

                                    IMPORTANT

     Any shareholder  desiring to tender all or any portion of the shareholder's
shares should either:

     |X|  Request the  shareholder's  broker,  dealer,  commercial  bank,  trust
          company  or  other   nominee  to  effect  the   transaction   for  the
          shareholder.  A shareholder whose shares are registered in the name of
          a broker, dealer, commercial bank, trust company or other nominee must
          contact such broker,  dealer,  commercial bank, trust company or other
          nominee if the shareholder desires to tender such shares; or

     |X|  Complete and sign the letter of transmittal  (or a facsimile  thereof)
          in accordance with the instructions in the letter of transmittal, have
          the shareholder's signature guaranteed if required by Instruction 1 to
          the letter of  transmittal,  mail or deliver the letter of transmittal
          (or such facsimile),  or, in the case of a transfer  effected pursuant
          to the  book-entry  transfer  procedures  set  forth in "THE  OFFER --
          Section 7," transmit an "agent's message" (as defined in "THE OFFER --
          Section 6"), and any other  required  documents to the  depositary and
          either  deliver the  certificates  for such  shares to the  depositary
          along with the letter of  transmittal  (or such  facsimile) or deliver
          the shares pursuant to the book-entry transfer procedures set forth in
          "THE OFFER -- Section 7."

If a  shareholder  desires to tender shares and the share  certificates  are not
immediately  available,  or the  procedure  for  book-entry  transfer  cannot be
completed on a timely basis,  or time will not permit all required  documents to
reach the depositary prior to the "expiration  date" (as defined  herein),  then
the tender may be effected by following the procedure  for  guaranteed  delivery
set forth in "THE OFFER -- Section 7."

Questions  and requests for  assistance  may be directed to MacKenzie  Partners,
Inc., the information  agent,  at the address and telephone  number set forth on
the back cover of this  offering  document.  Additional  copies of this offering
document, the letter of transmittal, the notice of guaranteed delivery and other
related materials may be obtained from the information agent.


                    THE INFORMATION AGENT FOR THIS OFFER IS:
                               [GRAPHIC OMITTED]
                            MACKENZIE PARTNERS, INC.





The following  information amends and supplements the Amended and Restated Offer
to Purchase dated May 24, 2005 (the "Restated Offer to Purchase"), as amended by
the  Supplement  dated  September  13, 2005  relating to the  Restated  Offer to
Purchase (the "First  Supplement"),  the  Supplement No. 2 dated January 3, 2006
relating  to  the  Restated   Offer  to   Purchase,   as  amended  (the  "Second
Supplement"),  and the  Supplement  No. 3 dated April 25,  2006  relating to the
Restated  Offer to Purchase,  as amended (the "Third  Supplement"),  of the Lola
Brown Trust No. 1B, an irrevocable  grantor trust domiciled and  administered in
South Dakota (the "Trust",  and also referred to herein as "we," "our" or "us"),
pursuant  to which the Trust is offering  to  purchase  up to  1,620,000  of the
outstanding  shares of common stock,  par value $0.0001 per share (the "shares")
of  Neuberger  Berman  Real  Estate  Income  Fund Inc.,  a Maryland  corporation
("NRL"),  not owned by the Trust,  at a price of $19.89  per  share,  net to the
seller in cash (subject to  applicable  withholding  of United  States  federal,
state and local  taxes),  without  interest,  upon the terms and  subject to the
conditions set forth in this Supplement No. 4 to the Restated Offer to Purchase,
as  amended  (the  "Fourth  Supplement"),   the  Third  Supplement,  the  Second
Supplement, the First Supplement, the Restated Offer to Purchase and the related
letter of  transmittal  (which,  together  with any  amendments  or  supplements
thereto, collectively constitute the "Offer").


Except  as  otherwise  set  forth  in this  Fourth  Supplement,  the  terms  and
conditions set forth in the Third Supplement,  the Second Supplement,  the First
Supplement,  the Restated  Offer to Purchase and the letter of  transmittal  are
applicable in all respects to the Offer.  The information set forth below should
be read in conjunction with the Third  Supplement,  the Second  Supplement,  the
First  Supplement,  the Restated Offer to Purchase and the letter of transmittal
and terms not defined herein which are defined in the Restated Offer to Purchase
have the meanings ascribed to them in the Restated Offer to Purchase.


                              QUESTIONS AND ANSWERS


How have you amended the offer?

     We are amending our offer to extend the expiration  date and to provide you
     with  information  regarding  NRL's adoption of a new poison pill set forth
     below in this  Supplement.  We have not changed the number of shares we are
     offering to purchase,  the offer price,  the  procedures  for tendering and
     withdrawing  shares or any of the other  terms of our offer  other than the
     expiration date.

What is the new expiration date for the offer?

     We are extending the  expiration  date for the offer to 5:00 P.M., New York
     City Time on Friday, December 8, 2006, unless further extended.

Why did you extend the expiration date for the offer?

     In order to halt the offer,  NRL's Board of Directors  has adopted a series
     of stockholder rights plans, or poison pills, which are required by federal
     law to expire no later than 120 days  after the  issuance  of rights  under
     each plan. The first poison pill was adopted by NRL's Board of Directors in
     September of 2004 and expired on January 21, 2005,  the second  poison pill
     was  adopted on January 18,  2005 and  expired on May 18,  2005,  the third
     poison pill was adopted on May 13, 2005 and expired on September  11, 2005,
     the fourth  poison  pill was  adopted on  September  1, 2005 and expired on
     December 23,  2005,  the fifth poison pill was adopted on December 21, 2005
     and  expired on April 17,  2006 and the sixth  poison  pill was  adopted on
     April 12, 2006 and expired on August 10, 2006.  Our offer was  scheduled to
     expire on August 15,  2006.  NRL's board has now  adopted a seventh  poison
     pill, largely identical to the previous ones. This seventh poison pill will
     expire on December 5, 2006.  The validity of the seventh  poison pill,  and
     whether  NRL's  Board of  Directors  can  continue  to adopt  poison  pills
     indefinitely, are two of the issues in our litigation with NRL.

     Because we cannot  close the offer while a poison pill  continues to exist,
     we do not  expect  to close  the  offer  unless  we are  successful  in our
     litigation against NRL's poison pills as well as certain of the other steps
     NRL has taken to halt the offer.  On October 22, 2004, the federal court in
     Maryland issued the poison pill order upholding the validity of NRL's first
     poison  pill.  We filed an appeal of the  poison  pill  order to the United
     States Court of Appeals for the Fourth Circuit. The appeals court dismissed
     our appeal on January 25, 2005,  with  permission to refile our appeal once
     all matters in the litigation  have been resolved at the trial court level.
     In  November  and  December of 2005,  NRL and we filed  motions for summary
     judgment  with the trial  court with  respect  to the  matters on which the
     trial court did not rule in its poison pill order,  and those  motions were
     argued and  submitted  to the  district  court on April 28,  2006,  and are
     pending  decision.  We have extended the  expiration  date for our offer to
     preserve our offer while we continue to seek a final  judgment in our favor
     with respect to NRL's seventh poison pill and other matters involved in the
     litigation.

If I already tendered my shares in the offer, do I have to do anything now?

     No.  Shareholders who validly tendered their shares previously and have not
     withdrawn  them do not have to take any  further  action.  If the  Offer is
     completed,  these  shares  will be accepted  for payment and the  tendering
     shareholders  will  receive  the offer  price of $19.89  per share in cash,
     without interest, less any required withholding taxes, subject to proration
     if more shares have been tendered in the Offer than we have offered to buy.
     See "THE OFFER -- Section 5."


Can I withdraw my previously tendered shares?

     You may withdraw all or a portion of your tendered shares at any time prior
     to the time the shares are accepted for payment, after which they cannot be
     withdrawn. See "THE OFFER -- Section 8."

How do I withdraw previously tendered shares?

     To withdraw  shares,  you must deliver a written notice of withdrawal  with
     the required  information to the depositary  while you still have the right
     to  withdraw  the  shares.  If you have  tendered  your  shares  by  giving
     instructions to a bank, broker, dealer, trust company or other nominee, you
     must instruct them to arrange for the  withdrawal of your shares.  See "THE
     OFFER -- Section 8."

What are the new business addresses for you and parties related to you?

     In the  Restated  Offer to  Purchase,  we  provided  you  with  information
     regarding  us and our  trustees  and certain  other  related  parties.  The
     business addresses for us and certain of those related parties has changed.
     Our new business  address,  and the new business  address for the Evergreen
     Trust,  the  Susan L.  Ciciora  Trust,  the John S.  Horejsi  Trust and the
     Stewart West Indies Trust, is: c/o Badlands Trust Company,  LLC, c/o Alaska
     First Bank & Trust, Attention: Ron Kukes, 3301 C Street, Anchorage,  Alaska
     99503. The new business address for Badlands Trust Company, LLC, the Ernest
     Trust and the Stewart  Trust is: c/o Alaska First Bank & Trust,  Attention:
     Ron Kukes, 3301 C Street, Anchorage, Alaska 99503. The new business for Ron
     Kukes is: 3301 C Street, Anchorage, Alaska 99503.

How many shares have been tendered in response to your offer?

     As of the close of business  on August 11,  2006,  10,865  shares have been
     tendered for sale to us in response to our offer.

Who can I contact if I have additional questions about the offer?

     If you have questions or you need assistance,  you should contact MacKenzie
     Partners,  Inc.,  the  information  agent for the offer,  at (212) 929-5500
     (collect) or (800) 322-2885 (toll-free).


                                  MISCELLANEOUS

The Offer is not being made to, nor will  tenders be accepted  from or on behalf
of,  holders of shares in any  jurisdiction  in which the making of the Offer or
the acceptance thereof would not comply with the laws of that  jurisdiction.  We
are not aware of any jurisdiction in which the making of the Offer or the tender
of shares in connection  therewith  would not be in compliance  with the laws of
such jurisdiction. If we become aware of any state law prohibiting the making of
the Offer or the acceptance of shares  pursuant  thereto in such state,  we will
make a good faith  effort to comply with any such state  statute or seek to have
such state statute declared inapplicable to the Offer. If, after such good faith
effort, we cannot comply with any such state statute, the Offer will not be made
to (nor will tenders be accepted  from or on behalf of) the holders of shares in
such jurisdiction.  In any jurisdiction where the securities,  blue sky or other
laws  require  the Offer to be made by a licensed  broker or  dealer,  the Offer
shall be deemed to be made on  behalf  of the  Trusts by one or more  registered
brokers or dealers which are licensed under the laws of such jurisdiction.

No  person  has  been  authorized  to  give  any  information  or  to  make  any
representation  on our behalf not  contained in the Offer and, if given or made,
that  information  or  representation  must  not be  relied  on as  having  been
authorized.

We filed with the SEC a Schedule TO dated September 10, 2004, an Amendment No. 1
to Schedule TO dated  October 1, 2004,  an Amendment  No. 2 to Schedule TO dated
October 7, 2004,  an Amendment  No. 3 to Schedule TO dated  October 14, 2004, an
Amendment  No. 4 to Schedule TO dated  October 26, 2004,  an Amendment  No. 5 to
Schedule TO dated  November  5, 2004,  an  Amendment  No. 6 to Schedule TO dated
January 25,  2005,  an  Amendment  No. 7 to Schedule TO dated May 24,  2005,  an
Amendment  No. 8 to Schedule TO dated  September 13, 2005, an Amendment No. 9 to
Schedule  TO dated  January 3, 2006,  an  Amendment  No. 10 to Schedule TO dated
April 25, 2006 and an  Amendment  No. 11 to Schedule TO dated  August 14,  2006,
under  Exchange Act Rule 14d-3,  together with exhibits,  furnishing  additional
information  with  respect  to the  Offer,  and may file  additional  amendments
thereto.  That schedule and any amendments thereto,  including exhibits,  may be
examined  and copies  may be  obtained  from the  offices of the SEC in the same
manner as  discussed  in "THE OFFER -- Section 12" with  respect to  information
concerning NRL.

                                                          LOLA BROWN TRUST NO.1B


August 14, 2006




     Facsimile copies of the letter of transmittal,  properly completed and duly
executed,  will be accepted. The letter of transmittal,  certificates for shares
and any other required documents should be sent or delivered by each shareholder
of NRL or his or her broker,  dealer,  commercial  bank,  trust company or other
nominee to the depositary at one of its addresses set forth below:

                        The Depositary for the Offer is:

                             The Colbent Corporation

                                                                                             



                 By Mail:                               By Overnight Courier:                              By Hand:
          The Colbent Corporation                      The Colbent Corporation                     The Colbent Corporation
          Attn: Corporate Actions                      Attn: Corporate Actions                     Attn: Corporate Actions
                POB 859208                               161 Bay State Drive                         161 Bay State Drive
          Braintree MA 02185-9208                        Braintree MA  02184                         Braintree MA  02184



                                  By Facsimile:
                                 (781-380-3388)

                         Confirm Facsimile Transmission:
                             (781-843-1833 Ext. 200)

     Questions and requests for  assistance  may be directed to the  information
agent at its address and telephone  numbers listed below.  Additional  copies of
this  Supplement,  the Offer to Purchase,  the letter of  transmittal  and other
tender offer materials may be obtained from the information  agent,  and will be
furnished  promptly at our expense.  You may also  contact your broker,  dealer,
commercial  bank,  trust company or other nominee for assistance  concerning the
Offer.



                     The Information Agent for the Offer is:
                               [GRAPHIC OMITTED]

                            MACKENZIE PARTNERS, INC.
                               105 Madison Avenue
                            New York, New York 10016
                          (212) 929-5500 (Call Collect)
                                       or
                           (800) 322-2885 (Toll Free)

                       E-MAIL: proxy@mackenziepartners.com